The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term real-world outcomes of axicabtagene ciloleucel (axi-cel) in relapsed/refractory (R/R) large B-cell lymphoma (LBCL).
 
Caron Jacobson
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; Autolus; Caribou Biosciences; Celgene/Bristol-Myers Squibb; Genentech; Genmab; Janssen; Kite, a Gilead Company; Kyverna Therapeutics; Lyell Immunopharma; Miltenyi Biotec; Novartis; Sana Biotechnology; Synthekine; Umoja Biopharma
Research Funding - Kite, a Gilead Company
 
Tanya Siddiqi
Consulting or Advisory Role - Abbvie; AstraZeneca; BeOne Medicines; Bristol-Myers Squibb; Kite, a Gilead Company; Pfizer
Research Funding - Ascentage Pharma (Inst); BeOne Medicines (Inst); Bristol-Myers Squibb (Inst); Pfizer; Umoja Biopharma (Inst)
 
Sairah Ahmed
Consulting or Advisory Role - ADC Therapeutics; Bristol-Myers Squibb; Genmab; Kite, a Gilead Company
Research Funding - Bristol-Myers Squibb; Caribou Biosciences; Genmab; Janssen; Kite, a Gilead Company; Merck; Nektar
 
Armin Ghobadi
Honoraria - Kite, a Gilead Company
Consulting or Advisory Role - Amgen; Atara Biotherapeutics; Bristol-Myers Squibb; Crispr Therapeutics; Kite, a Gilead Company; WUGEN, Inc.
Research Funding - Amgen; Genentech; Kite, a Gilead Company
 
David Miklos
Honoraria - Fosun Kite
Consulting or Advisory Role - Bristol-Myers Squibb; Galapagos NV; Miltenyi Biotec; Novartis
Research Funding - 2seventy bio; Adaptive Biotechnologies; Adicet Bio; Allogene Therapeutics; Kite, a Gilead Company
Patents, Royalties, Other Intellectual Property - Janssen
Travel, Accommodations, Expenses - Kite, a Gilead Company
 
Yi Lin
Consulting or Advisory Role - Adicet Bio (Inst); Bristol-Myers Squibb (Inst); Caribou Biosciences (Inst); Chimeric Therapeutics (Inst); Fosun Kite (Inst); Genentech (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Nektar (Inst); NexImmune (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Tessera (Inst); Vineti (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Janssen Oncology (Inst)
 
Miguel-Angel Perales
Honoraria - Abbvie; Astellas Oncology; Celgene/Bristol-Myers Squibb; Gilead Sciences; Incyte; Karyopharm Therapeutics; Kite, a Gilead Company; Miltenyi Biotec; MorphoSys; Nektar; Novartis; Takeda
Consulting or Advisory Role - Merck; Omeros
Research Funding - Incyte; Kite, a Gilead Company; Miltenyi Biotec; Novartis
Other Relationship - Cidara; Medigene; SERVIER
 
Matthew Lunning
Consulting or Advisory Role - Abbvie; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Fate Therapeutics; Genentech; Genentech; Incyte; Ipsen; Kite, a Gilead company; Loxo; Pfizer; Recordati; VITTORIA
Research Funding - curis (Inst); FATE THERAPEUTICS
 
Megan Herr
No Relationships to Disclose
 
Brian Hill
Honoraria - Kite, a Gilead Company
Consulting or Advisory Role - Kite, a Gilead Company
Research Funding - Kite, a Gilead Company
Travel, Accommodations, Expenses - Kite, a Gilead Company
 
Siddhartha Ganguly
No Relationships to Disclose
 
Waleska Perez
No Relationships to Disclose
 
Zhongyu Feng
No Relationships to Disclose
 
Timothy Best
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Gilead Sciences
 
Grace Lee
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Kite, a Gilead Company
 
Olga Nikolajeva
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Kite, a Gilead company
 
Brad Du
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Gilead Sciences
 
Babatunde Adedokun
Employment - Amgen; Kite, a Gilead Company
Stock and Other Ownership Interests - Gilead Sciences
Travel, Accommodations, Expenses - Amgen; Kite, a Gilead Company
 
Samantha Jaglowski
Consulting or Advisory Role - Cardinal Health; crispr therapeutics
 
Frederick Locke
Employment - Moffitt Cancer Center
Consulting or Advisory Role - A2 Biotherapeutics; Adaptimmune; Adaptive Biotechnologies; Alimera Sciences; Amgen; AstraZeneca; Bluebird Bio; Bristol-Myers Squibb; Bristol-Myers Squibb/Celgene; Calibr; Caribou Biosciences; Celgene; Cowen; Daiichi Sankyo/UCB Japan; EcoR1 Capital; Gerson Lehrman Group; Iovance Biotherapeutics; Janssen; Kite, a Gilead company; Legend Biotech; Miltenyi Biotec; Novartis; Pfizer; Poseida; Sana Biotechnology; Takeda
Research Funding - 2seventy bio (Inst); Alimera Sciences (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb/Celgene (Inst); Incyte (Inst); Kite, a Gilead company (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - CAR T Cells with Enhanced Metabolic Fitness. Serial Number: 62/939,727 (Inst); Double Mutant Survivin Vaccine. US010414810B2. (Inst); Evolutionary Dynamics of Non-Hodgkin Lymphoma CAR-T cell therapy. Serial Number: 62/879,534. (Inst); Methods of Enhancing CAR T Cell Therapies. Serial Number: 62/892,292. (Inst)
Travel, Accommodations, Expenses - A2 Biotherapeutics; Kite, a Gilead company